Radiation-induced skin cancer in humans

被引:77
作者
Shore, RE [1 ]
机构
[1] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 2001年 / 36卷 / 05期
关键词
ionizing radiation; nonmelanoma skin cancer; basal cell carcinoma; squamous cell carcinoma; malignant melanoma;
D O I
10.1002/mpo.1128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The principal epidemiologic studies of ionizing radiation and skin cancer have all shown that radiation causes basal cell carcinoma but have not found dose-related excesses of squamous cell carcinoma or malignant melanoma. The Japanese atomic bomb study indicates that doses of radiation under about 1 Gy confer less risk per unit dose than higher doses do. All available studies show that skin cancer risk is greater from radiation exposure at young ages than at older ages. Finding few excess skin cancers among irradiated African-Americans as compared to Caucasians with a comparable dose indicates that skin susceptibility to ultraviolet exposure modifies the excess risk from ionizing radiation. Available evidence indicates that the excess risk of skin cancer lasts for 45 years or more following irradiation. Several studies indicate a risk of nonmelanoma skin cancer (NMSC) following cancer therapy; however, most of the studies reporting on NMSC have not distinguished between patients who received radiotherapy versus chemotherapy. Some, but not all, follow-up studies of cancer patients have reported excesses of malignant melanoma as second malignant neoplasms. II is not clear from the studies how much, ii any, of the excess melanoma risk is attributable to radiotherapy. Med. Pediatr. Oncol. 36:549-554, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:549 / 554
页数:6
相关论文
共 51 条
[1]   2ND MALIGNANCIES AFTER TREATMENT OF HODGKINS-DISEASE - THE INFLUENCE OF TREATMENT, FOLLOW-UP TIME, AND AGE [J].
ABRAHAMSEN, JF ;
ANDERSEN, A ;
HANNISDAL, E ;
NOME, O ;
ABRAHAMSEN, AF ;
KVALOY, S ;
HOST, H .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (02) :255-261
[2]  
AUSTIN DF, 1981, LANCET, V2, P712
[3]  
BOICE JD, 1985, J NATL CANCER I, V74, P955
[4]   INCIDENCE OF 2ND CANCERS IN PATIENTS TREATED FOR HODGKINS-DISEASE [J].
BOIVIN, JF ;
HUTCHISON, GB ;
ZAUBER, AG ;
BERNSTEIN, L ;
DAVIS, FG ;
MICHEL, RP ;
ZANKE, B ;
TAN, CTC ;
FULLER, LM ;
MAUCH, P ;
ULTMANN, JE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (10) :732-741
[5]  
Brennan P, 2000, BRIT J CANCER, V82, P1344
[6]  
Committee on the Biological Effects of Ionizing Radiation (BEIR V), 1990, HLTH EFFECTS EXPOSUR
[7]   Solid cancers after bone marrow transplantation [J].
Curtis, RE ;
Rowlings, PA ;
Deeg, HJ ;
Shriner, DA ;
Socie, G ;
Travis, LB ;
Horowitz, MM ;
Witherspoon, RP ;
Hoover, RN ;
Sobocinski, KA ;
Fraumeni, JF ;
Boice, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :897-904
[8]   SKIN-CANCER IN PATIENTS WITH CHRONIC RADIATION DERMATITIS [J].
DAVIS, MM ;
HANKE, CW ;
ZOLLINGER, TW ;
MONTEBELLO, JF ;
HORNBACK, NB ;
NORINS, AL .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (04) :608-616
[9]   2ND NON-GERM CELL MALIGNANCIES AFTER RADIOTHERAPY OF TESTICULAR CANCER WITH OR WITHOUT CHEMOTHERAPY [J].
FOSSA, SD ;
LANGMARK, F ;
AASS, N ;
ANDERSEN, A ;
LOTHE, R ;
BORRESEN, AL .
BRITISH JOURNAL OF CANCER, 1990, 61 (04) :639-643
[10]  
Frieben E., 1902, ROFO FORTSCHR RONTG, V6, P106